Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $9,162 | $11,200 | $9,161 | $18,817 |
| % Growth | -18.2% | 22.3% | -51.3% | – |
| Cost of Goods Sold | $5,609 | $9,659 | $8,087 | $15,224 |
| Gross Profit | $3,553 | $1,541 | $1,075 | $3,593 |
| % Margin | 38.8% | 13.8% | 11.7% | 19.1% |
| R&D Expenses | $1,501 | $1,871 | $2,042 | $1,654 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6,530 | $5,551 | $5,250 | $6,946 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,182 | $0 | $0 | $0 |
| Operating Expenses | $6,849 | $7,422 | $7,292 | $8,600 |
| Operating Income | -$3,379 | -$5,991 | -$6,218 | -$8,050 |
| % Margin | -36.9% | -53.5% | -67.9% | -42.8% |
| Other Income/Exp. Net | $2,551 | -$708 | -$728 | -$734 |
| Pre-Tax Income | -$827 | -$6,699 | -$6,946 | -$8,784 |
| Tax Expense | $28 | $1,636 | $0 | $6 |
| Net Income | -$855 | -$6,699 | -$6,946 | -$8,790 |
| % Margin | -9.3% | -59.8% | -75.8% | -46.7% |
| EPS | -0.035 | -0.26 | -0.23 | -0.29 |
| % Growth | 86.5% | -13% | 20.7% | – |
| EPS Diluted | -0.035 | -0.26 | -0.23 | -0.29 |
| Weighted Avg Shares Out | 24,299 | 32,275 | 30,223 | 30,090 |
| Weighted Avg Shares Out Dil | 24,299 | 32,275 | 30,223 | 30,090 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,090 | $0 | $728 | $734 |
| Depreciation & Amortization | $686 | $766 | $613 | $599 |
| EBITDA | $1,508 | -$5,115 | -$5,605 | -$9,761 |
| % Margin | 16.5% | -45.7% | -61.2% | -51.9% |